Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring.

Zhong W, Celli JP, Rizvi I, Mai Z, Spring BQ, Yun SH, Hasan T.

Br J Cancer. 2009 Dec 15;101(12):2015-22. doi: 10.1038/sj.bjc.6605436. Epub 2009 Nov 17.

2.

Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model.

Molpus KL, Kato D, Hamblin MR, Lilge L, Bamberg M, Hasan T.

Cancer Res. 1996 Mar 1;56(5):1075-82.

3.

Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.

Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T.

Cancer Res. 2010 Nov 15;70(22):9319-28. doi: 10.1158/0008-5472.CAN-10-1783. Epub 2010 Nov 9.

4.

Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.

Lilge L, Molpus K, Hasan T, Wilson BC.

Photochem Photobiol. 1998 Sep;68(3):281-8.

PMID:
9747583
5.

Effects of photodynamic therapy on adhesion molecules and metastasis.

Rousset N, Vonarx V, Eléouet S, Carré J, Kerninon E, Lajat Y, Patrice T.

J Photochem Photobiol B. 1999 Sep-Oct;52(1-3):65-73.

PMID:
10643074
6.

Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).

Akens MK, Hardisty MR, Wilson BC, Schwock J, Whyne CM, Burch S, Yee AJ.

Breast Cancer Res Treat. 2010 Jan;119(2):325-33. doi: 10.1007/s10549-009-0356-7. Epub 2009 Mar 5.

PMID:
19263216
7.

Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.

Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M, Hasan T.

Br J Cancer. 1994 Sep;70(3):474-80.

8.

Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.

Tong ZS, Miao PT, Liu TT, Jia YS, Liu XD.

Acta Pharmacol Sin. 2012 Oct;33(10):1319-24. doi: 10.1038/aps.2012.45. Epub 2012 Jul 30.

9.

PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy.

Ichikawa K, Hikita T, Maeda N, Takeuchi Y, Namba Y, Oku N.

Biol Pharm Bull. 2004 Mar;27(3):443-4.

10.

Vascular effects of photodynamic and pulsed dye laser therapy protocols.

Channual J, Choi B, Osann K, Pattanachinda D, Lotfi J, Kelly KM.

Lasers Surg Med. 2008 Nov;40(9):644-50. doi: 10.1002/lsm.20673.

11.

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

Fingar VH, Kik PK, Haydon PS, Cerrito PB, Tseng M, Abang E, Wieman TJ.

Br J Cancer. 1999 Apr;79(11-12):1702-8.

12.
13.

A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.

Lange N, Ballini JP, Wagnieres G, van den Bergh H.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):38-46.

PMID:
11133846
14.

Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.

Weston MA, Patterson MS.

Photochem Photobiol. 2011 Sep-Oct;87(5):1129-37. doi: 10.1111/j.1751-1097.2011.00942.x. Epub 2011 Jul 7.

PMID:
21575000
15.

Application of long-circulating liposomes to cancer photodynamic therapy.

Oku N, Saito N, Namba Y, Tsukada H, Dolphin D, Okada S.

Biol Pharm Bull. 1997 Jun;20(6):670-3.

PMID:
9212988
16.

Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.

Trauner KB, Gandour-Edwards R, Bamberg M, Shortkroff S, Sledge C, Hasan T.

Photochem Photobiol. 1998 Jan;67(1):133-9.

PMID:
9477771
17.

Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.

Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N.

Cancer. 2003 Apr 15;97(8):2027-34.

18.

Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors.

Osaki T, Takagi S, Hoshino Y, Okumura M, Kadosawa T, Fujinaga T.

J Vet Med Sci. 2009 Feb;71(2):125-32.

19.

Experimental photodynamic laser therapy for rheumatoid arthritis with a second generation photosensitizer.

Hendrich C, Hüttmann G, Vispo-Seara JL, Houserek S, Siebert WE.

Knee Surg Sports Traumatol Arthrosc. 2000;8(3):190-4.

PMID:
10883433
20.

High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.

Busetti A, Soncin M, Jori G, Rodgers MA.

Br J Cancer. 1999 Feb;79(5-6):821-4.

Supplemental Content

Support Center